Fabrice Zéni

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial

Jean-François Dhainaut, Alain Tenaillon, Yves Le Tulzo et al. · Critical Care Medicine · 1994 · 236 citations

Acute Respiratory Distress Syndrome and Risk of AKI among Critically Ill Patients

Michaël Darmon, Christophe Clec’h, Christophe Adrie et al. · Clinical Journal of the American Society of Nephrology · 2014 · 221 citations · Full text

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial

Jean-François Dhainaut, Alain Tenaillon, Jean-Pierre Solet et al. · Critical Care Medicine · 1994 · 199 citations

Severe Sepsis, Pharmacotherapy, Mortality Rates +20

High Sensitivity and Specificity of Serum Procalcitonin Levels in Adults with Bacterial Meningitis

Alain Viallon, Fabrice Zéni, Claude Lambert et al. · Clinical Infectious Diseases · 1999 · 173 citations · Full text

Medical Diagnostics, Serum Procalcitonin Levels, High Sensitivity +12

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis

Jean-François Dhainaut, Alain Tenaillon, M. Hemmer et al. · Critical Care Medicine · 1998 · 154 citations